Heterogeneity of epidermal growth factor receptor mutations in lung adenocarcinoma harboring anaplastic lymphoma kinase rearrangements: A case report

Case Report ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Growth Factor Receptor ◽

Anaplastic Lymphoma ◽

CT radiomics-based prediction of anaplastic lymphoma kinase and epidermal growth factor receptor mutations in lung adenocarcinoma

European Journal of Radiology ◽

10.1016/j.ejrad.2021.109710 ◽

2021 ◽

pp. 109710

Author(s):

Jooae Choe ◽

Sang Min Lee ◽

Wooil Kim ◽

Kyung-Hyun Do ◽

Seonok Kim ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Growth Factor Receptor ◽

Anaplastic Lymphoma ◽

Echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase rearrangement and epidermal growth factor receptor mutation coexisting in Chinese patients with lung adenocarcinoma

Thoracic Cancer ◽

10.1111/1759-7714.12111 ◽

2014 ◽

Vol 5 (5) ◽

pp. 411-416 ◽

Cited By ~ 1

Author(s):

Jianfei Zhu ◽

Ling Cai ◽

Haoxian Yang ◽

Yinsheng Wen ◽

Junye Wang ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Growth Factor Receptor ◽

Chinese Patients ◽

Anaplastic Lymphoma ◽

The diagnosis and incidence of epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) mutation in lung adenocarcinoma

10.1183/13993003.congress-2015.pa4250 ◽

2015 ◽

Author(s):

Chung-Jen Huang ◽

Wen-Hui Ku

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Growth Factor Receptor ◽

Anaplastic Lymphoma ◽

Clinical and computed tomography features (CT) of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutation and anaplastic lymphoma kinase (ALK) status

10.1183/13993003.congress-2020.1696 ◽

2020 ◽

Author(s):

Rosa Abril Castañon Perez ◽

Gustavo Gutiérrez Herrero ◽

Haizea Álvarez Martínez ◽

Pablo Lozano Cuesta ◽

Omar Sánchez Martin ◽

...

Keyword(s):

Computed Tomography ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Egfr Mutation ◽

Growth Factor Receptor ◽

Anaplastic Lymphoma ◽

Comparison of clinical and radiological characteristics between anaplastic lymphoma kinase rearrangement and epidermal growth factor receptor mutation in treatment naïve advanced lung adenocarcinoma

Journal of Thoracic Disease ◽

10.21037/jtd.2017.08.134 ◽

2017 ◽

Vol 9 (10) ◽

pp. 3927-3937 ◽

Cited By ~ 6

Author(s):

Yingying Miao ◽

Suhua Zhu ◽

Huijuan Li ◽

Jiawei Zou ◽

Qingqing Zhu ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Growth Factor Receptor ◽

Anaplastic Lymphoma ◽

Treatment Naïve ◽

MicroRNA 25 , microRNA 145 , and microRNA 210 as biomarkers for predicting the efficacy of maintenance treatment with pemetrexed in lung adenocarcinoma patients who are negative for epidermal growth factor receptor mutations or anaplastic lymphoma kinase translocations

Translational Research ◽

10.1016/j.trsl.2015.11.006 ◽

2016 ◽

Vol 170 ◽

pp. 1-7 ◽

Cited By ~ 13

Author(s):

Sheng-Bin Shi ◽

Meng Wang ◽

Jing Tian ◽

Rui Li ◽

Chun-Xiao Chang ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Maintenance Treatment ◽

Growth Factor Receptor ◽

Anaplastic Lymphoma ◽

Poor response to gefitinib in lung adenocarcinoma with concomitant epidermal growth factor receptor mutation and anaplastic lymphoma kinase rearrangement

Thoracic Cancer ◽

10.1111/1759-7714.12146 ◽

2015 ◽

Vol 6 (2) ◽

pp. 216-219 ◽

Cited By ~ 8

Author(s):

Jianya Zhou ◽

Jing Zheng ◽

Jing Zhao ◽

Yihong Sheng ◽

Wei Ding ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Lung Adenocarcinoma ◽

Growth Factor Receptor ◽

Poor Response ◽

Anaplastic Lymphoma ◽

A Case of Synchronous Multiple Primary Lung Adenocarcinomas Harboring Epidermal Growth Factor Receptor Mutation and Anaplastic Lymphoma Kinase Rearrangement Successfully Treated with Combination of Osimertinib and Alectinib

Respiratory Medicine Case Reports ◽

10.1016/j.rmcr.2021.101418 ◽

2021 ◽

pp. 101418

Author(s):

Yukihisa Inoue ◽

Osamu Matsubara ◽

Yumi Ohira ◽

Satoshi Endo ◽

Yasuto Jinn

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Anaplastic Lymphoma ◽

Multiple Primary ◽

Epidermal Growth ◽

Lung Adenocarcinomas

First-line pemetrexed and carboplatin plus anlotinib for epidermal growth factor receptor wild-type and anaplastic lymphoma kinase-negative lung adenocarcinoma with brain metastasis

Medicine ◽

10.1097/md.0000000000022128 ◽

2020 ◽

Vol 99 (36) ◽

pp. e22128 ◽

Cited By ~ 1

Author(s):

Chu Zhang ◽

Feng-Wei Kong ◽

Wen-Bin Wu ◽

Miao Zhang ◽

Guang-Mao Yu ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Brain Metastasis ◽

Growth Factor Receptor ◽

Wild Type ◽

First Line ◽

Anaplastic Lymphoma ◽

Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report

BMC Research Notes ◽

10.1186/1756-0500-6-489 ◽

2013 ◽

Vol 6 (1) ◽

Cited By ~ 29

Author(s):

Henrik H Rossing ◽

Morten Grauslund ◽

Edyta M Urbanska ◽

Linea C Melchior ◽

Charlotte K Rask ◽

...

Keyword(s):

Case Report ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Acquired Resistance ◽

Growth Factor Receptor ◽

Anaplastic Lymphoma ◽

Lung Adenocarcinoma Patient ◽

Epidermal Growth ◽

Viral Oncogene Homolog